查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1990115

消費者基因組學市場：2026-2032年全球市場預測（按產品類型、技術、測試類型、應用和最終用戶分類）

Consumer Genomics Market by Product Type, Technology, Test Type, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，消費者基因組學市場價值將達到 30.2 億美元，到 2026 年將成長至 36.6 億美元，到 2032 年將達到 125.6 億美元，複合年成長率為 22.54%。

主要市場統計數據
基準年 2025 30.2億美元
預計年份：2026年 36.6億美元
預測年份 2032 125.6億美元
複合年成長率 (%) 22.54%

權威地介紹了不斷發展的消費者基因組學生態系統以及塑造商業性和臨床路徑的融合力量。

消費者基因組學領域正處於一個關鍵的十字路口，科學創新、商業性雄心和社會關切以日益複雜的方式交織在一起。定序技術的最新進展，結合更先進的生物資訊學，降低了技術進入門檻，將消費者基因服務的範圍從祖源追溯擴展到健康、藥物基因體學和生活方式應用。這種擴張是由消費者對預防醫學和個人化健康日益成長的興趣所驅動的，這使得他們需要能夠提供可操作且可解讀的見解的檢測，而不僅僅是原始數據。

人工智慧驅動的分析、多體學整合、不斷發展的監管標準以及不斷變化的消費者期望如何重新定義基因組學領域的競爭優勢。

消費者基因組學領域正經歷一系列變革性變化，這些變化正在重塑其能力和競爭動態。人工智慧和先進的機器學習技術正在改進對基因突變的解讀，並實現更豐富的表現型-基因型關聯，從而提高消費者報告的臨床相關性。定序技術的同步進步，尤其是在高通量平台和最佳化的樣品製備，正在擴大消費者規模檢測的準確性和範圍。

評估近期關稅變化對基因組產品跨境流動和商業化的多方面營運、策略和供應鏈影響。

2025年實施的關稅調整的累積影響，正為依賴跨境分銷設備、試劑和特殊組件的公司帶來一系列複雜的營運和策略後果。關稅上調提高了進口定序設備和某些耗材的接收成本，迫使供應鏈管理人員重新評估籌資策略。隨著企業努力降低關稅波動和運輸延誤的風險，這加速了關於供應商多元化和關鍵投入品近岸外包的討論。

詳細的細分洞察，清楚地展示了產品類型、技術、測試變化、應用和最終用戶需求如何獨特地影響策略重點和價值主張。

按產品類型進行的詳細分析揭示了策略重點和商業性趨勢的差異。試劑、試劑盒和定序耗材等耗材由於需要重複採購，因此需要檢測化學方面的持續創新和可靠的供應。分析儀和定序儀等儀器需要長期支援模式、現場服務安排和資金籌措方案，以降低檢查室和機構客戶的採用門檻。服務，包括直接面對消費者的檢測和專業檢測服務，需要不同的客戶參與模式。前者強調使用者體驗和報告清晰度，而後者則優先考慮臨床相關性和互通性。包括數據分析工具和報告平台在內的軟體產品，在提供解讀價值和支援後續臨床操作方面正發揮越來越重要的作用。

區域比較分析解釋了監管複雜性、基礎設施成熟度和消費者行為如何塑造差異化的部署和夥伴關係策略。

區域趨勢影響全球消費者基因組學產業的採納路徑、監管互動和合作機會。在美洲，成熟的直接面對消費者市場、強勁的私人投資以及充滿活力的臨床研究生態系統共同促進了產品的快速改進和多元化的經營模式。在監管方面，消費者保護和檢查室標準至關重要，而關於保險報銷的討論在臨床基因檢測這一細分領域也變得日益重要。

企業策略和競爭方法展示了垂直整合、臨床夥伴關係和資料管治如何創造差異化和長期競爭優勢。

消費者基因組學生態系統中的主要企業正並行推行多項策略，以維持並擴大其競爭優勢。這些策略包括：透過整合偵測能力和軟體平台深化垂直整合；管理端到端的客戶體驗；以及透過訂閱服務確保持續收入。此外，他們還利用與臨床實驗室、保險公司和研究機構的策略合作夥伴關係，驗證臨床效用，並開闢報銷管道，從而方便患者在醫療保健系統內獲得特定檢測服務。

領導者可採取切實可行的策略步驟，以提高臨床可靠性、加強供應鏈並利用資料管理作為市場差異化優勢。

產業領導者可以採取多項具體措施來管理結構性風險，同時最大限度地掌握新機會。首先，他們可以透過調整產品藍圖，優先發展那些具有明確臨床或行為學相關人員的測試和服務，來加強與臨床合作夥伴和保險公司利害關係人的關係。其次，他們可以投資健全的資料管理實踐，超越合規要求，建立信任，進而打造市場差異化優勢。這包括透明的知情同意模式、可互通的數據標準以及嚴格的網路安全措施。

調查方法詳細介紹了為確保獲得穩健且符合倫理的見解和檢驗的研究結果而採用的混合方法、專家訪談和檢驗實踐。

本分析採用混合方法，結合質性和量性調查方法，旨在得出嚴謹且可操作的見解。主要研究包括對測試營運、研發領導、法規事務和商業化團隊等領域的產業從業人員進行結構化訪談，並輔以臨床和政策顧問的專家諮詢。次要研究則納入了同行評審文獻、監管指南、技術白皮書和公開的技術文件，並基於檢驗的證據進行分析。

結論強調，保持永續的領導地位需要科學創新和臨床檢驗、健全的管治以及適應性強的商業策略相結合。

總而言之，消費者基因體學領域正處於技術潛力和實際限制的交會點，蘊藏著影響預防醫學、個人化治療和消費者健康的巨大機會。儘管定序、生物資訊學和解讀演算法的進步正在帶來更多可操作的結果，但商業性的成功需要一種綜合方法，將臨床檢驗、可靠的數據管理和適應性供應鏈管理相結合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：消費者基因體學市場：依產品類型分類

  • 消耗品
    • 試劑和試劑盒
    • 耗材定序
  • 裝置
    • 分析器
    • 序列器
  • 服務
    • 面向一般消費者的測試
    • 專業測試服務
  • 軟體
    • 數據分析工具
    • 報告創建軟體

第9章：消費者基因體學市場：依技術分類

  • 生物資訊學和計算工具
  • CRISPR技術
  • DNA定序
  • 微陣列技術
  • 次世代定序
  • 聚合酵素鏈鎖反應
  • 單核苷酸多態性（SNP）基因型鑒定

第10章：消費者基因體學市場測試的類型

  • 祖源搜尋
  • 基因帶原檢測
  • 營養基因體學檢測
  • 腫瘤科檢查
    • 癌症風險評估
    • 腫瘤DNA分析
  • 預測性和無症狀檢測

第11章 消費者基因體學市場：依應用領域分類

  • 祖源與根源分析
  • 攜帶者篩檢
  • 訂製護膚和化妝品
  • 疾病預防與管理
  • 健康與保健
  • 生活方式和個人特徵
  • 微生物組分析
  • 親子關係與家庭關係
  • 藥物基因體學

第12章 消費者基因體學市場：依最終用戶分類

  • 學術和研究機構
  • 生技公司
  • 健康與健康中心
  • 製藥公司

第13章 消費者基因體學市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 消費者基因體學市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 消費者基因體學市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國消費者基因體學市場

第17章：中國消費者基因體學市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 10x Genomics, Inc.
  • 23andMe, Inc.
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation by Konica Minolta, Inc.
  • Ancestry
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Color Health, Inc.
  • Dante Labs Inc.
  • Decode Genetics by Amgen Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Full Genomes Corporation, Inc.
  • Gene by Gene, Ltd.
  • Helix, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • LetsGetChecked, Inc.
  • Living DNA Ltd
  • MyHeritage Ltd.
  • Nebula Genomics, Inc. by ProPhase Labs, Inc.
  • Oxford Nanopore Technologies PLC
  • QIAGEN GmbH
  • SeqLL Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-5D693B46C019

The Consumer Genomics Market was valued at USD 3.02 billion in 2025 and is projected to grow to USD 3.66 billion in 2026, with a CAGR of 22.54%, reaching USD 12.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.02 billion
Estimated Year [2026] USD 3.66 billion
Forecast Year [2032] USD 12.56 billion
CAGR (%) 22.54%

An authoritative introduction to the evolving consumer genomics ecosystem and the converging forces shaping commercial and clinical pathways

The consumer genomics landscape is at a pivotal juncture where scientific innovation, commercial ambition, and societal concerns intersect in increasingly complex ways. Recent advances in sequencing technologies, coupled with more sophisticated bioinformatics, have lowered technical barriers to entry and expanded the scope of consumer-facing genetic services beyond ancestry into health, pharmacogenomics, and lifestyle applications. This expansion has been accompanied by rising consumer interest in preventive health and personalized wellness, driving demand for tests that promise actionable, interpretable insights rather than raw data alone.

Concurrently, the industry faces intensifying scrutiny around data privacy, consent models, and the ethical use of genomic information. Regulators, payers, and clinical stakeholders are pushing for clearer evidence of clinical utility and standardized reporting formats that support integration into care pathways. Industry participants are responding by strengthening clinical validation, investing in secure data architectures, and collaborating with healthcare systems to demonstrate value.

Looking forward, sustained progress will hinge on the ability of providers to balance consumer expectations for convenience and affordability with robust governance, transparent value propositions, and clinically relevant outcomes. Strategic alignment across R&D, commercialization, and policy engagement will determine which organizations convert present opportunity into enduring leadership.

How AI driven interpretation, multi-omic integration, evolving regulatory standards, and shifting consumer expectations are redefining competitive advantage in genomics

The landscape of consumer genomics is being reshaped by a cluster of transformative shifts that are altering both capability and competitive dynamics. Artificial intelligence and advanced machine learning are enhancing variant interpretation and enabling richer phenotype-genotype correlations, which in turn improve the clinical relevance of consumer-facing reports. Parallel improvements in sequencing technologies, especially higher-throughput platforms and optimized library preparations, are increasing the fidelity and scope of tests that can be delivered at consumer scale.

Moreover, gene-editing advances and broader multi-omic integration are expanding the conceptual boundaries of what consumer genomics can inform, moving the industry from single-test outputs toward interconnected biological insights. Regulatory regimes are evolving in response, prompting companies to refine consent frameworks, strengthen data provenance controls, and seek partnerships with clinical laboratories and healthcare systems to validate utility. At the same time, consumer expectations are maturing: buyers increasingly favor services that offer clear actionability, ongoing care pathways, and transparent data practices rather than one-time reports.

These shifts are producing a market environment where agility in technology adoption, credibility in clinical validation, and trustworthiness in data stewardship are now core competitive differentiators. Organizations that can integrate these elements while maintaining operational efficiency will secure the strongest positions for sustained growth.

Assessing the multifaceted operational, strategic, and supply chain consequences of recent tariff changes on cross-border genomics product flows and commercialization

The cumulative effects of tariff changes enacted in 2025 have imposed a complex set of operational and strategic consequences for companies that rely on cross-border flows of instruments, reagents, and specialized components. Supply chain managers have had to reassess sourcing strategies as increased duties raise landed costs for imported sequencing instruments and certain consumables. This has accelerated conversations around supplier diversification and nearshoring for critical inputs, as organizations seek to reduce exposure to tariff volatility and transit-related delays.

These trade policy shifts have also influenced commercial decision-making. Some providers have absorbed incremental costs to preserve price competitiveness, while others have adjusted service tiers and bundling strategies to offset margin compression. In parallel, procurement teams have intensified vendor consolidation efforts in order to negotiate more favorable terms and to secure priority allocation of constrained items. Regulatory compliance and customs documentation requirements have also increased administrative burden, prompting investments in trade compliance capabilities and expanded coordination between commercial and logistics functions.

Longer term, the tariff environment has stimulated localized manufacturing initiatives and strategic partnerships with regional suppliers. While these adaptations can mitigate risk and shorten lead times, they require capital reallocation and time to build capacity. As a result, organizations that proactively redesign supply networks, lock in strategic supplier relationships, and align inventory strategies with regulatory and market signals will be better positioned to manage the downstream effects of trade policy changes.

Detailed segmentation insights that articulate how product types, technologies, test variations, applications, and end-user demands uniquely influence strategic priorities and value delivery

A granular view across product types reveals differentiated strategic priorities and commercial dynamics. Consumables, including reagents, kits, and sequencing consumables, demand continuous innovation in assay chemistry and supply reliability, given the recurring nature of purchases. Instruments such as analyzers and sequencers require long-term support models, field service capabilities, and financing options that lower adoption friction for laboratory and institutional customers. Services span direct-to-consumer tests and professional testing services, each requiring distinct customer engagement models: the former focuses on user experience and report clarity, while the latter emphasizes clinical validity and interoperability. Software offerings, including data analysis tools and report generation platforms, are increasingly central to delivering interpretive value and enabling downstream clinical action.

On the technology axis, bioinformatics and computational tools are essential for scalable interpretation, while DNA sequencing and next-generation sequencing serve as foundational laboratory modalities. Polymerase chain reaction remains indispensable for targeted assays, and single nucleotide polymorphism genotyping supports cost-effective screening use cases. Emerging technologies such as CRISPR-based assays and microarray platforms offer specialized capabilities that can complement mainstream sequencing approaches.

Test type segmentation highlights the diversity of consumer interest: ancestry testing continues to attract curiosity-led demand, carrier and predictive testing target reproductive planning and preventive care, nutrigenomics and lifestyle assessments appeal to wellness-oriented consumers, and oncology testing focuses on both cancer risk assessment and tumor DNA analysis with direct clinical implications. Applications range from ancestry and heritage analysis to pharmacogenomics and microbiome analysis, each with unique evidentiary and regulatory expectations.

End-users encompass academic and research institutes that require high-throughput solutions, biotechnology companies focused on R&D pipelines, health and wellness centers building consumer programs, and pharmaceutical companies leveraging genomic insights for drug development and patient stratification. Recognizing these distinctions enables firms to prioritize investments, tailor commercialization models, and design differentiated service levels that meet the nuanced needs of each segment.

Comparative regional intelligence describing how regulatory complexity, infrastructure maturity, and consumer behaviors shape differentiated adoption and partnership strategies

Regional dynamics shape adoption pathways, regulatory interactions, and partnership opportunities across the global consumer genomics industry. In the Americas, a combination of mature direct-to-consumer markets, robust private investment, and active clinical research ecosystems has promoted rapid product iteration and diverse commercial models. Regulatory focus emphasizes consumer protection and laboratory standards, and reimbursement discussions are increasingly relevant in clinical genetic testing niches.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and data protection frameworks such as strong privacy regimes influence how companies approach cross-border data flows and localized operations. Public healthcare systems in parts of Europe create pathways for clinical integration when tests demonstrate utility, while in other regional markets private pay and out-of-pocket models predominate. Data localization requirements and variable laboratory infrastructure necessitate flexible operating models and partnerships with regional clinical laboratories.

The Asia-Pacific region is characterized by rapid adoption curves, significant investment in local manufacturing and genomics capacity, and a wide spectrum of regulatory maturity. High population density and large cohorts offer compelling opportunities for population-scale studies and personalized medicine initiatives, while rising consumer health awareness fuels demand for ancestry, wellness, and pharmacogenomic services. Across all regions, successful market entry depends on aligning offerings with local regulatory expectations, establishing trusted clinical and distribution partners, and adapting consumer engagement strategies to cultural norms and health literacy levels.

Corporate strategy and competitive approaches illustrating how vertical integration, clinical partnerships, and data governance drive differentiation and long-term advantage

Leading organizations in the consumer genomics ecosystem are pursuing several concurrent strategies to protect and extend competitive advantage. They are deepening vertical integration by combining laboratory capabilities with software platforms to control the end-to-end customer experience and to capture recurring revenue through subscription services. Strategic collaborations with clinical laboratories, payers, and research institutions are being used to validate clinical utility and to open reimbursement pathways that make certain tests more accessible within healthcare systems.

Investment in data governance and cyber resilience has become a strategic priority, with companies implementing stronger consent frameworks, encryption standards, and auditability to maintain trust with consumers and institutional partners. At the same time, go-to-market strategies are diversifying: some players emphasize consumer-branding and direct engagement, while others focus on enterprise and clinical channels that deliver scale through institutional adoption. R&D portfolios are balancing incremental assay improvements with platform-level investments in automation, AI-driven interpretation, and scalable reporting infrastructure.

Competitive differentiation is increasingly predicated on the ability to demonstrate validated outcomes, integrate seamlessly with clinical workflows, and offer transparent value propositions that align with payer and provider incentives. Organizations that combine these operational capabilities with disciplined commercial execution will be best positioned to win in both consumer and clinical domains.

Actionable strategic measures for leaders to strengthen clinical credibility, fortify supply chains, and leverage data stewardship as a market differentiator

Industry leaders can adopt several concrete actions to capitalize on emerging opportunities while managing structural risks. First, align product roadmaps to prioritize assays and services that demonstrate clear clinical or behavioral actionability, thereby strengthening relationships with clinical partners and payer stakeholders. Second, invest in robust data stewardship practices that go beyond compliance to establish trust as a market differentiator; this includes transparent consent models, interoperable data standards, and rigorous cybersecurity measures.

Third, redesign supply chain strategies to reduce exposure to geopolitical shocks and tariff volatility by diversifying suppliers, considering regional manufacturing partnerships, and maintaining strategic inventory buffers for critical consumables. Fourth, accelerate software and AI investments that enhance interpretive accuracy and enable scalable personalization, ensuring that algorithmic decisions are explainable and clinically validated. Fifth, tailor commercial approaches by segment: deliver streamlined user experiences for consumer channels while building evidence-driven value propositions for clinical and enterprise customers.

Finally, engage proactively with policymakers and standards bodies to shape pragmatic regulatory frameworks that balance innovation with consumer protection. By executing these steps, organizations will improve resilience, unlock new revenue streams, and create differentiated value for both consumers and clinical stakeholders.

Research methodology detailing mixed methods, expert consultations, and triangulation practices used to ensure robust, ethically grounded insights and validated findings

This analysis was developed through a mixed-methods approach combining qualitative and quantitative research techniques designed to produce rigorous, actionable insights. Primary research included structured interviews with industry practitioners across laboratory operations, R&D leadership, regulatory affairs, and commercialization teams, supplemented by expert consultations with clinical and policy advisors. Secondary research incorporated peer-reviewed literature, regulatory guidance, technology white papers, and publicly available technical documentation to ground the analysis in verifiable evidence.

Data synthesis emphasized triangulation across sources to validate thematic findings, while the segmentation framework guided targeted investigation into product types, technologies, test use cases, applications, and end-user needs. Care was taken to document assumptions and to identify areas where evidence is nascent, recommending further validation where appropriate. Quality assurance processes included methodological reviews, fact-checking, and iterative stakeholder feedback loops to refine conclusions and ensure relevance to decision-makers.

Ethical considerations were central to the research design, with attention to data privacy, potential conflicts of interest, and the responsible communication of scientific uncertainty. Limitations are acknowledged where available evidence is evolving rapidly, and recommended next steps include focused primary research and pilot studies to validate high-impact strategic hypotheses.

Conclusive synthesis highlighting the imperative to pair scientific innovation with clinical validation, robust governance, and adaptive commercial strategies for sustained leadership

In summary, the consumer genomics field stands at the intersection of technological possibility and real-world constraints, with substantial opportunity to influence preventive care, personalized treatment, and consumer wellness. Advancements in sequencing, bioinformatics, and interpretive algorithms are enabling more actionable outputs, but commercial success requires an integrated approach that couples clinical validation with trustworthy data practices and adaptive supply chain management.

Regulatory shifts and trade policy developments are reshaping operational imperatives, prompting investments in compliance, localized manufacturing, and strategic partnerships. Meanwhile, market segmentation points to differentiated value propositions across consumables, instruments, services, and software, and across technology, test type, application, and end-user dimensions. Companies that prioritize evidence of clinical utility, secure data stewardship, and seamless interoperability will find the most traction with healthcare systems and discerning consumers alike.

Ultimately, organizations that combine scientific rigor with pragmatic execution-focusing investments where they enable measurable clinical or behavioral impact-will convert current momentum into sustainable leadership. The path forward requires disciplined strategy, collaborative partnerships, and an unwavering commitment to responsible innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Consumer Genomics Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Reagents & Kits
    • 8.1.2. Sequencing Consumables
  • 8.2. Instruments
    • 8.2.1. Analyzers
    • 8.2.2. Sequencers
  • 8.3. Services
    • 8.3.1. Direct-to-Consumer Tests
    • 8.3.2. Professional Testing Services
  • 8.4. Software
    • 8.4.1. Data Analysis Tools
    • 8.4.2. Report Generation Software

9. Consumer Genomics Market, by Technology

  • 9.1. Bioinformatics & Computational Tools
  • 9.2. CRISPR Technology
  • 9.3. DNA Sequencing
  • 9.4. Microarray Technology
  • 9.5. Next-Generation Sequencing
  • 9.6. Polymerase Chain Reaction
  • 9.7. Single Nucleotide Polymorphism (SNP) Genotyping

10. Consumer Genomics Market, by Test Type

  • 10.1. Ancestry Testing
  • 10.2. Carrier Testing
  • 10.3. Nutrigenomics Testing
  • 10.4. Oncology Testing
    • 10.4.1. Cancer Risk Assessment
    • 10.4.2. Tumor DNA Analysis
  • 10.5. Predictive & Presymptomatic Testing

11. Consumer Genomics Market, by Application

  • 11.1. Ancestry & Heritage Analysis
  • 11.2. Carrier Screening
  • 11.3. Custom Skincare & Cosmetics
  • 11.4. Disease Prevention & Management
  • 11.5. Health & Wellness
  • 11.6. Lifestyle & Personal Traits
  • 11.7. Microbiome Analysis
  • 11.8. Paternity & Familial Relationships
  • 11.9. Pharmacogenomics

12. Consumer Genomics Market, by End-User

  • 12.1. Academic & Research Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Health & Wellness Centers
  • 12.4. Pharmaceutical Companies

13. Consumer Genomics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Consumer Genomics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Consumer Genomics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Consumer Genomics Market

17. China Consumer Genomics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 10x Genomics, Inc.
  • 18.6. 23andMe, Inc.
  • 18.7. Agilent Technologies, Inc.
  • 18.8. Ambry Genetics Corporation by Konica Minolta, Inc.
  • 18.9. Ancestry
  • 18.10. BGI Group
  • 18.11. Bio-Rad Laboratories, Inc.
  • 18.12. Color Health, Inc.
  • 18.13. Dante Labs Inc.
  • 18.14. Decode Genetics by Amgen Inc.
  • 18.15. Eurofins Scientific SE
  • 18.16. F. Hoffmann-La Roche Ltd
  • 18.17. Full Genomes Corporation, Inc.
  • 18.18. Gene by Gene, Ltd.
  • 18.19. Helix, Inc.
  • 18.20. Illumina, Inc.
  • 18.21. Invitae Corporation
  • 18.22. LetsGetChecked, Inc.
  • 18.23. Living DNA Ltd
  • 18.24. MyHeritage Ltd.
  • 18.25. Nebula Genomics, Inc. by ProPhase Labs, Inc.
  • 18.26. Oxford Nanopore Technologies PLC
  • 18.27. QIAGEN GmbH
  • 18.28. SeqLL Inc.
  • 18.29. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONSUMER GENOMICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONSUMER GENOMICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCING CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCING CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCING CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PROFESSIONAL TESTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PROFESSIONAL TESTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PROFESSIONAL TESTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DATA ANALYSIS TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DATA ANALYSIS TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DATA ANALYSIS TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REPORT GENERATION SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REPORT GENERATION SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REPORT GENERATION SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOINFORMATICS & COMPUTATIONAL TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOINFORMATICS & COMPUTATIONAL TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOINFORMATICS & COMPUTATIONAL TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CRISPR TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CRISPR TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NUTRIGENOMICS TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NUTRIGENOMICS TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY NUTRIGENOMICS TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CANCER RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CANCER RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CANCER RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TUMOR DNA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TUMOR DNA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY TUMOR DNA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PREDICTIVE & PRESYMPTOMATIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PREDICTIVE & PRESYMPTOMATIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PREDICTIVE & PRESYMPTOMATIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY & HERITAGE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY & HERITAGE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ANCESTRY & HERITAGE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CUSTOM SKINCARE & COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CUSTOM SKINCARE & COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY CUSTOM SKINCARE & COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DISEASE PREVENTION & MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DISEASE PREVENTION & MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY DISEASE PREVENTION & MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY LIFESTYLE & PERSONAL TRAITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY LIFESTYLE & PERSONAL TRAITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY LIFESTYLE & PERSONAL TRAITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROBIOME ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROBIOME ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY MICROBIOME ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PATERNITY & FAMILIAL RELATIONSHIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PATERNITY & FAMILIAL RELATIONSHIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PATERNITY & FAMILIAL RELATIONSHIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY HEALTH & WELLNESS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 230. GCC CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. GCC CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 233. GCC CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. GCC CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 235. GCC CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 239. GCC CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. GCC CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 263. G7 CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. G7 CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 266. G7 CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. G7 CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 269. G7 CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. G7 CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. G7 CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 272. G7 CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. G7 CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 274. NATO CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. NATO CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. NATO CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 277. NATO CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. NATO CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. NATO CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. NATO CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 283. NATO CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. NATO CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL CONSUMER GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA CONSUMER GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA CONSUMER GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA CONSUMER GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA CONSUMER GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA CONSUMER GENOMICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA CONSUMER GENOMICS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA CONSUMER GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA CONSUMER GENOMICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA CONSUMER GENOMICS MARKET SIZE, BY ONCOLOGY TESTING, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA CONSUMER GENOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA CONSUMER GENOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)